NI202100055A - Formas de sal y cristalinas de un compuesto orgánico y composiciones farmacéutica del mismo. - Google Patents
Formas de sal y cristalinas de un compuesto orgánico y composiciones farmacéutica del mismo.Info
- Publication number
- NI202100055A NI202100055A NI202100055A NI202100055A NI202100055A NI 202100055 A NI202100055 A NI 202100055A NI 202100055 A NI202100055 A NI 202100055A NI 202100055 A NI202100055 A NI 202100055A NI 202100055 A NI202100055 A NI 202100055A
- Authority
- NI
- Nicaragua
- Prior art keywords
- crystalline forms
- pharmaceutical compositions
- salt
- organic compound
- salts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/16—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
- C07D249/18—Benzotriazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4192—1,2,3-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
En la presente se proporcionan diversas sales, que incluyen sales de tris(hidroximetil)aminometano y sales de sodio, así como diversas formas cristalinas del compuesto representado por la fórmula estructural: También se proporcionan composiciones farmacéuticas que comprenden estas sales y formas cristalinas, métodos para su fabricación, y usos de las mismas para tratar condiciones, incluyendo, pero no limitado a, condiciones que se beneficiarían de la inhibición de dihidroorotato deshidrogenasa (DHODH).
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862784083P | 2018-12-21 | 2018-12-21 | |
| US201962791571P | 2019-01-11 | 2019-01-11 | |
| US201962882712P | 2019-08-05 | 2019-08-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NI202100055A true NI202100055A (es) | 2021-12-01 |
Family
ID=69185721
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NI202100055A NI202100055A (es) | 2018-12-21 | 2021-06-21 | Formas de sal y cristalinas de un compuesto orgánico y composiciones farmacéutica del mismo. |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20220055995A1 (es) |
| EP (1) | EP3898597A1 (es) |
| JP (1) | JP2022515239A (es) |
| KR (1) | KR20220035022A (es) |
| CN (1) | CN113508108A (es) |
| AU (1) | AU2019403396A1 (es) |
| BR (1) | BR112021012305A2 (es) |
| CA (1) | CA3124401A1 (es) |
| CL (1) | CL2021001640A1 (es) |
| CO (1) | CO2021009309A2 (es) |
| CR (1) | CR20210394A (es) |
| IL (1) | IL284218A (es) |
| JO (1) | JOP20210147A1 (es) |
| MA (1) | MA54541A (es) |
| MX (1) | MX2021007536A (es) |
| NI (1) | NI202100055A (es) |
| PE (1) | PE20212197A1 (es) |
| SG (1) | SG11202106526UA (es) |
| TW (1) | TW202039448A (es) |
| WO (1) | WO2020132471A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI818954B (zh) | 2018-02-20 | 2023-10-21 | 法商施維雅藥廠 | 三取代之苯并三唑衍生物的使用方法 |
| EP4203950A1 (en) | 2020-08-27 | 2023-07-05 | Servier Pharmaceuticals LLC | Use of a dhodh inhibitor compound in combination cancer therapy |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2228367A1 (en) * | 2009-03-13 | 2010-09-15 | Almirall, S.A. | Addition salts of amines containing hydroxyl and/or carboxylic groups with amino nicotinic acid derivatives as DHODH inhibitors |
| TW201733984A (zh) | 2011-04-13 | 2017-10-01 | 雅酶股份有限公司 | 經取代之苯化合物 |
| US9360932B1 (en) | 2012-08-29 | 2016-06-07 | Intellect Motion Llc. | Systems and methods for virtually displaying real movements of objects in a 3D-space by means of 2D-video capture |
| CN103965133B (zh) * | 2013-01-31 | 2018-11-30 | 华东理工大学 | 一种具有dhodh抑制活性的含n、s杂环化合物及其制备和用途 |
| HUE042032T2 (hu) | 2013-02-25 | 2019-06-28 | Aurigene Discovery Tech Ltd | Triszubsztituált benzotriazol-származékok, melyek dihidro-orotát-oxigenáz-inhibitor hatásúak |
| US20180369206A1 (en) * | 2017-04-24 | 2018-12-27 | Aurigene Discovery Technologies Limited | Methods of Use for Trisubstituted Benzotriazole Derivatives as Dihydroorotate Oxygenase Inhibitors |
-
2019
- 2019-12-20 CR CR20210394A patent/CR20210394A/es unknown
- 2019-12-20 US US17/416,910 patent/US20220055995A1/en active Pending
- 2019-12-20 TW TW108147117A patent/TW202039448A/zh unknown
- 2019-12-20 WO PCT/US2019/067897 patent/WO2020132471A1/en active Application Filing
- 2019-12-20 CN CN201980091991.XA patent/CN113508108A/zh active Pending
- 2019-12-20 JP JP2021536323A patent/JP2022515239A/ja active Pending
- 2019-12-20 CA CA3124401A patent/CA3124401A1/en active Pending
- 2019-12-20 BR BR112021012305-9A patent/BR112021012305A2/pt unknown
- 2019-12-20 EP EP19839747.3A patent/EP3898597A1/en active Pending
- 2019-12-20 PE PE2021001052A patent/PE20212197A1/es unknown
- 2019-12-20 AU AU2019403396A patent/AU2019403396A1/en active Pending
- 2019-12-20 SG SG11202106526UA patent/SG11202106526UA/en unknown
- 2019-12-20 MX MX2021007536A patent/MX2021007536A/es unknown
- 2019-12-20 MA MA054541A patent/MA54541A/fr unknown
- 2019-12-20 JO JOP/2021/0147A patent/JOP20210147A1/ar unknown
- 2019-12-20 KR KR1020217022945A patent/KR20220035022A/ko unknown
-
2021
- 2021-06-18 CL CL2021001640A patent/CL2021001640A1/es unknown
- 2021-06-20 IL IL284218A patent/IL284218A/en unknown
- 2021-06-21 NI NI202100055A patent/NI202100055A/es unknown
- 2021-07-15 CO CONC2021/0009309A patent/CO2021009309A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20220035022A (ko) | 2022-03-21 |
| MX2021007536A (es) | 2021-09-23 |
| EP3898597A1 (en) | 2021-10-27 |
| SG11202106526UA (en) | 2021-07-29 |
| CL2021001640A1 (es) | 2022-06-03 |
| MA54541A (fr) | 2022-03-09 |
| CN113508108A (zh) | 2021-10-15 |
| AU2019403396A1 (en) | 2021-07-08 |
| CR20210394A (es) | 2021-12-13 |
| CO2021009309A2 (es) | 2021-10-29 |
| JOP20210147A1 (ar) | 2023-01-30 |
| CA3124401A1 (en) | 2020-06-25 |
| PE20212197A1 (es) | 2021-11-16 |
| US20220055995A1 (en) | 2022-02-24 |
| IL284218A (en) | 2021-08-31 |
| BR112021012305A2 (pt) | 2021-10-05 |
| JP2022515239A (ja) | 2022-02-17 |
| WO2020132471A1 (en) | 2020-06-25 |
| TW202039448A (zh) | 2020-11-01 |
| WO2020132471A8 (en) | 2020-08-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CU20210009A7 (es) | Compuestos derivados de tieno pirrolo-triazina acetamida sustituida como inhibidores de la actividad inflamatoria de la proteína receptora tipo nod 3 (nlrp3) | |
| ECSP18094790A (es) | Piridinas sustituidas con heteroarilo y métodos de uso referencia cruzada a solicitudes relacionadas | |
| CU20200046A7 (es) | Compuestos de 1,2,4-oxadiazol como inhibidores de las vías de señalización de cd47 | |
| UY37537A (es) | Derivados de pirazol como inhibidores malt1 | |
| CU20180152A7 (es) | Pirimidin-2-ilamino-1h-pirazoles útiles como inhibidores de lrrk2 | |
| CU20160097A7 (es) | Compuestos de imidazopirazina como inhibidores de syk | |
| CU20160188A7 (es) | Compuestos de indazole substituidos como inhibidores de irak4 | |
| CO6852096A2 (es) | Métodos plaguicidasque utilizan compuestos de 3-piridil tiazol sustituidos y derivados para combatir las plagas de animales i | |
| CO2018000589A2 (es) | Oxiesteroles y composiciones farmacéuticas que los contienen | |
| EA201690094A1 (ru) | Ингибиторы syk | |
| CU24603B1 (es) | Imidazopirimidinas diazabicíclicas sustituidas útiles en el tratamiento de trastornos respiratorios | |
| CL2017002745A1 (es) | Nuevos compuestos y derivados de sulfonimidoilpurinona para el tratamiento y profilaxis de infecciones víricas | |
| CU20150084A7 (es) | Derivados del ácido 4-((1,1) bisfenil -4-il)-3-(3-fosfonopropanamido)butanoico,activo como inhibidores de nep(endopeptidasa neutral) | |
| CO2021009309A2 (es) | Formas de sal y cristalinas de un compuesto orgánico y composiciones farmacéuticas del mismo | |
| DOP2016000308A (es) | Compuestos de 1, 3, 4-tiadiazol y uso de los mismos para el tratamiento del cáncer | |
| CL2020000376A1 (es) | Compuesto pentacíclico. | |
| EA201990238A1 (ru) | ФОСФОРСОДЕРЖАЩИЕ ПРОЛЕКАРСТВА СТИМУЛЯТОРОВ sGC | |
| CR20160029A (es) | Compuestos de pirimidino sustituido y derivados para combatir plagas de animales | |
| ECSP19013196A (es) | Derivado de triazolopirazinona útil como un inhibidor de pde1 humana | |
| MX2020004842A (es) | Compuestos heterociclicos antiinfecciosos y sus usos. | |
| BR112022009493A2 (pt) | Fabricação de do3a protegido | |
| AR094858A1 (es) | Derivados de isoxazolina como compuestos insecticidas | |
| CO2019007836A2 (es) | Derivados de pirrolotriazina como inhibidor de cinasas | |
| BR112020026507A8 (pt) | Composto de isotiazolo[5,4-d]pirimidinas como inibidor de irak4 | |
| BR112016019569A2 (pt) | Compostos herbicidas |